Estrella Immunopharma (ESLA)

• Market cap: $42M
• 1 day: -5.34%
• 5 days: -3.47%
• 1 month: -12.95%
• 3 months: -5.34%
• 6 months: -36.27%
• Year to date: -29.86%
• 1 year: 1.56%
• 5 years: -90%
• 10 years: -90%
• Sector: Healthcare
• Industry: Biotechnology

About: Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.